HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stability, disposition, and penetration of catalytic antioxidants Mn-porphyrin and Mn-salen and of methylprednisolone in spinal cord injury.

Abstract
This study measured the time courses of concentration changes following administration of the catalytic antioxidants Mn (III) tetrakis (4-benzoic acid) porphyrin (MnTBAP) and Mn (III) 3-methoxy N, N' bis (salicyclidene) ethylenediamine chloride (EUK-134) in blood and cerebrospinal fluid (CSF) of rats with a spinal cord injury (SCI) and sham controls. Parallel measurements were made for methylprednisolone, the only drug presently used clinically for treating SCI. The time courses kinetically characterized the agents in their stability, disposition, and ability to penetrate the blood-spinal cord barrier (BSB). In both the SCI and control groups, MnTBAP was stable in CSF and in blood across the collection periods (10 h and 24 h, respectively) following administration. In the blood, [EUK-134] and [methylprednisolone] rapidly declined to near basal concentrations at 4 h and 2 h, respectively, post-administration. Therefore the order of stability in CSF and blood was MnTBAP >> EUK-134 > methylprednisolone. The maximum CSF/blood concentration ratios for EUK-134, methylprednisolone and MnTBAP post-administration were: 32 ± 3.1%, 19.2 ± 6.4%, and 4.42 ± 0.73% in the injured rats, and 22 ± 6.5%, 17.8 ± 2.9%, and 1.0 ± 0.5% in the sham control animals. This suggests an order of BSB penetration of EUK-134 > methylprednisolone >> MnTBAP. Despite much lower penetration by MnTBAP compared with EUK-134 and methylprednisolone, a lower dose of MnTBAP because of its stability provided a higher concentration in CSF than did the other agents given at higher doses. This finding supports further exploration of MnTBAP as a potential treatment for SCI.
AuthorsLiqin Wu, Yichu Shan, Danxia Liu
JournalCentral nervous system agents in medicinal chemistry (Cent Nerv Syst Agents Med Chem) Vol. 12 Issue 2 Pg. 122-30 (Jun 2012) ISSN: 1875-6166 [Electronic] United Arab Emirates
PMID22640221 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Antioxidants
  • EUK-134
  • Metalloporphyrins
  • Mn-salen
  • Organometallic Compounds
  • Protoporphyrins
  • Salicylates
  • manganese(III)-tetrakis(4-benzoic acid)porphyrin
  • manganese protoporphyrin
  • Manganese
  • Methylprednisolone
Topics
  • Animals
  • Antioxidants (chemistry, metabolism, therapeutic use)
  • Catalytic Domain (drug effects)
  • Drug Stability
  • Male
  • Manganese (chemistry, metabolism, therapeutic use)
  • Metalloporphyrins
  • Methylprednisolone (chemistry, metabolism, therapeutic use)
  • Organometallic Compounds (chemistry, metabolism, therapeutic use)
  • Protoporphyrins (chemistry, metabolism, therapeutic use)
  • Rats
  • Rats, Sprague-Dawley
  • Salicylates
  • Spinal Cord Injuries (drug therapy, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: